FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity
FXR/TGR5 双重激动剂可预防糖尿病和肥胖症引起的肾病进展
期刊:Journal of the American Society of Nephrology
影响因子:10.3
doi:10.1681/ASN.2017020222
Xiaoxin X Wang, Dong Wang, Yuhuan Luo, Komuraiah Myakala, Evgenia Dobrinskikh, Avi Z Rosenberg, Jonathan Levi, Jeffrey B Kopp, Amanda Field, Ashley Hill, Scott Lucia, Liru Qiu, Tao Jiang, Yingqiong Peng, David Orlicky, Gabriel Garcia, Michal Herman-Edelstein, Vivette D'Agati, Kammi Henriksen, Lucian